000 | 01630 a2200457 4500 | ||
---|---|---|---|
005 | 20250516173803.0 | ||
264 | 0 | _c20150409 | |
008 | 201504s 0 0 eng d | ||
022 | _a1099-1263 | ||
024 | 7 |
_a10.1002/jat.2928 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Si | |
245 | 0 | 0 |
_aTowards an integrated in vitro strategy for estrogenicity testing. _h[electronic resource] |
260 |
_bJournal of applied toxicology : JAT _cSep 2014 |
||
300 |
_a1031-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimal Testing Alternatives |
650 | 0 | 4 |
_aBiological Assay _xmethods |
650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEndocrine Disruptors _xtoxicity |
650 | 0 | 4 | _aEndpoint Determination |
650 | 0 | 4 |
_aEstrogen Receptor alpha _xgenetics |
650 | 0 | 4 |
_aEstrogens _xpharmacology |
650 | 0 | 4 | _aGenes, Reporter |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMCF-7 Cells |
650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aRNA-Binding Proteins |
650 | 0 | 4 | _aTranscriptional Activation |
700 | 1 | _aAarts, Jac M M J G | |
700 | 1 | _ade Haan, Laura H J | |
700 | 1 | _aArgyriou, Dimitrios | |
700 | 1 | _aPeijnenburg, Ad A C M | |
700 | 1 | _aRietjens, Ivonne M C M | |
700 | 1 | _aBovee, Toine F H | |
773 | 0 |
_tJournal of applied toxicology : JAT _gvol. 34 _gno. 9 _gp. 1031-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jat.2928 _zAvailable from publisher's website |
999 |
_c23160689 _d23160689 |